Covered recipient · General Payments record
SARAH R TUCKER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,545.04
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $499.28 | 17 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $268.48 | 6 |
| Amgen Inc. | $141.77 | 5 |
| Medtronic, Inc. | $127.91 | 4 |
| Exact Sciences Corporation | $21.71 | 1 |
| Lilly USA, LLC | $19.71 | 1 |
| Radius Health, Inc. | $19.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.47 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402746 | CMS |
| Amgen Inc. | $18.40 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402748 | CMS |
| Amgen Inc. | $70.29 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402754 | CMS |
| Amgen Inc. | $18.79 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402750 | CMS |
| Amgen Inc. | $20.82 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402752 | CMS |
| Astellas Pharma US Inc | $116.59 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139524046 | CMS |
| Astellas Pharma US Inc | $19.41 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139489272 | CMS |
| Astellas Pharma US Inc | $6.27 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139491460 | CMS |
| Astellas Pharma US Inc | $15.62 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139482856 | CMS |
| Astellas Pharma US Inc | $10.60 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139513215 | CMS |
| Astellas Pharma US Inc | $99.99 | 08/21/2024 | Education | Undisputed | 01/23/2026 | 1139526648 | CMS |
| Exact Sciences Corporation | $21.71 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114548345 | CMS |
| Lilly USA, LLC | $19.71 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933546 | CMS |
| Medtronic, Inc. | $35.47 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116954458 | CMS |
| Medtronic, Inc. | $21.50 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116954460 | CMS |
| Medtronic, Inc. | $46.22 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116954462 | CMS |
| Medtronic, Inc. | $24.72 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116954464 | CMS |
| Radius Health, Inc. | $19.69 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090040235 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.